138 related articles for article (PubMed ID: 28689065)
1. Improve the anticancer potency of the platinum(II) complexes through functionalized leaving group.
Zhao J; Wang D; Xu G; Gou S
J Inorg Biochem; 2017 Oct; 175():20-28. PubMed ID: 28689065
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
[TBL] [Abstract][Full Text] [Related]
3. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
6. Antitumor platinum(II) complexes of N-monoalkyl 1R,2R-diamino-cyclohexanes with 3-(nitrooxy)cyclobutane-1,1-dicarboxylate as a leaving group.
Zhao J; Gou S; Xu G; Cheng L
Eur J Med Chem; 2014 Oct; 85():408-17. PubMed ID: 25108080
[TBL] [Abstract][Full Text] [Related]
7. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
[TBL] [Abstract][Full Text] [Related]
8. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
Pang SK; So WK; Ho YP; Au-Yeung CF
Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
[TBL] [Abstract][Full Text] [Related]
9. The impact of different chelating leaving groups on the substitution kinetics of mononuclear Pt(II)(1,2-trans-R,R-diaminocyclohexane)(X-Y) complexes.
Summa N; Soldatović T; Dahlenburg L; Bugarcić ZD; van Eldik R
J Biol Inorg Chem; 2007 May; 12(4):461-75. PubMed ID: 17245597
[TBL] [Abstract][Full Text] [Related]
10. New imidoyl-indazole platinum (II) complexes as potential anticancer agents: Synthesis, evaluation of cytotoxicity, cell death and experimental-theoretical DNA interaction studies.
Cabrera AR; Espinosa-Bustos C; Faúndez M; Meléndez J; Jaque P; Daniliuc CG; Aguirre A; Rojas RS; Salas CO
J Inorg Biochem; 2017 Sep; 174():90-101. PubMed ID: 28648925
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.
Chen XZ; Ye QS; Lou LG; Xie MJ; Liu WP; Yu Y; Hou SQ
Arch Pharm (Weinheim); 2008 Feb; 341(2):132-6. PubMed ID: 18186542
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
13. Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand.
Zhao J; Gou S; Liu F
Chemistry; 2014 Nov; 20(46):15216-25. PubMed ID: 25256173
[TBL] [Abstract][Full Text] [Related]
14. Relevance of the leaving group for antitumor activity of new platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; Contaldi S; den Dulk H; Monari M; Brouwer J; Jaehde U; Kalayda GV; Reedijk J
J Inorg Biochem; 2009 Dec; 103(12):1602-8. PubMed ID: 19783310
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants.
Pages BJ; Li F; Wormell P; Ang DL; Clegg JK; Kepert CJ; Spare LK; Danchaiwijit S; Aldrich-Wright JR
Dalton Trans; 2014 Nov; 43(41):15566-75. PubMed ID: 25197979
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxicity, and apoptosis induction study of antitumor dinuclear platinum(II) complexes.
Xu G; Gou S; Gao C
Arch Pharm (Weinheim); 2013 Apr; 346(4):308-13. PubMed ID: 23447402
[TBL] [Abstract][Full Text] [Related]
17. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity and cellular response mechanisms of water-soluble platinum(II) complexes of lidocaine and phenylcyanamide derivatives.
Tabrizi L; Chiniforoshan H
Biometals; 2017 Feb; 30(1):59-70. PubMed ID: 27995355
[TBL] [Abstract][Full Text] [Related]
19. New Pt-NNSO core anticancer agents: Structural optimization and investigation of their anticancer activity.
Chong SX; Jin Y; Au-Yeung SC; To KK
J Inorg Biochem; 2017 May; 170():34-45. PubMed ID: 28214754
[TBL] [Abstract][Full Text] [Related]
20. Thermodynamic and kinetic studies on reactions of Pt(II) complexes with biologically relevant nucleophiles.
Summa N; Schiessl W; Puchta R; van Eikema Hommes N; van Eldik R
Inorg Chem; 2006 Apr; 45(7):2948-59. PubMed ID: 16562950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]